Hua Lin
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
-
- Mangiferin and Mango Extracts
Papers in
- Nephrology 12
- Gout, Hyperuricemia, Uric Acid 8
- Renal Diseases and Glomerulopathies 4
- Chronic Kidney Disease and Diabetes 3
-
- Inflammasome and immune disorders 4
- Co-authors
- Lihui Gao (10 shared papers)Yanfen Niu (10 shared papers)Junbiao Wu (6 shared papers)Jiuyao Zhou (6 shared papers)Junqi Chen (5 shared papers)Dandan Chen (3 shared papers)Bihao Liu (4 shared papers)Ruirui Lu (3 shared papers)
- Journals
- European Journal of Pharmacology (4 papers)Biological and Pharmaceutical Bulletin (3 papers)Journal of Pharmacological Sciences (2 papers)Pharmaceutical Biology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Hua Lin
19 papers receiving 585 citations
Peers
Comparison fields: 5 of 73
- Nephrology 176
- Complementary and alternative medicine 92
- Pharmacology 60
- Clinical Biochemistry 36
- Immunology 74
Countries citing papers authored by Hua Lin
This map shows the geographic impact of Hua Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Lin more than expected).
Fields of papers citing papers by Hua Lin
This network shows the impact of papers produced by Hua Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Lin. The network helps show where Hua Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hua Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 103 | |
| 2 | 2021 | 65 | |
| 3 | 2019 | 45 | |
| 4 | 2015 | 42 | |
| 5 | 2017 | 36 | |
| 6 | 2013 | 35 | |
| 7 | 2023 | 32 | |
| 8 | 2023 | 32 | |
| 9 | 2017 | 30 | |
| 10 | 2018 | 28 | |
| 11 | 2012 | 26 | |
| 12 | 2022 | 24 | |
| 13 | 2020 | 21 | |
| 14 | 2019 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2017 | 13 | |
| 17 | 2017 | 11 | |
| 18 | 2023 | 8 | |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Hua Lin
Hua Lin is a scholar working on Nephrology, Molecular Biology, Pathology and Forensic Medicine, Epidemiology and Complementary and alternative medicine, having authored 20 papers that have together received 589 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (8 papers), Renal Diseases and Glomerulopathies (4 papers), Inflammasome and immune disorders (4 papers), Alcohol Consumption and Health Effects (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Mangiferin and Mango Extracts (3 papers), Autophagy in Disease and Therapy (3 papers) and Case Reports on Hematomas (2 papers). The work is most often cited by research in Nephrology (176 citations), Complementary and alternative medicine (92 citations), Pharmacology (60 citations), Clinical Biochemistry (36 citations) and Immunology (74 citations). Hua Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Lihui Gao, Yanfen Niu, Junbiao Wu, Jiuyao Zhou, Junqi Chen, Dandan Chen, Bihao Liu, Ruirui Lu, Xiangwei Xu and Ling Li. Their work appears in journals such as European Journal of Pharmacology, Biological and Pharmaceutical Bulletin, Journal of Pharmacological Sciences, Pharmaceutical Biology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.